Kim and colleagues explored the role of NEK9 in CRC and found that the overexpression of the NEK9-EG5 axis is associated with the distal metastasis of CRC, suggesting that it may serve as a biomarker [60]. This evidence concerns the gene KIF11 and colorectal carcinoma.